- Home
- FENC vs XRPN Comparison
FENC vs XRPN Comparison
Compare FENC & XRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$10.71
Company Overview
Basic Information| Metric | FENC | XRPN |
|---|---|---|
| Founded | 1996 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.0M | 328.9M |
| IPO Year | 2010 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FENC | XRPN |
|---|---|---|
| Price | $10.71 | $16.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | 128.3K | ★ 840.1K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $62.55 | N/A |
| Revenue Next Year | $42.10 | N/A |
| P/E Ratio | $177.17 | ★ $72.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $10.10 |
| 52 Week High | $13.25 | $48.00 |
Technical Indicators
Market Signals| Indicator | FENC | XRPN |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 51.95 |
| Support Level | $9.84 | $10.35 |
| Resistance Level | $11.29 | N/A |
| Average True Range (ATR) | 0.50 | 4.38 |
| MACD | 0.02 | 0.88 |
| Stochastic Oscillator | 56.54 | 19.12 |
Price Performance
Historical Comparison FENC
XRPN
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About XRPN Armada Acquisition Corp. II Class A Ordinary Shares
Armada Acquisition Corp II is a blank check company.